|
Rep. Laura Fine
Filed: 4/19/2018
| | 10000HB4146ham002 | | LRB100 14115 JLS 38393 a |
|
|
| 1 | | AMENDMENT TO HOUSE BILL 4146
|
| 2 | | AMENDMENT NO. ______. Amend House Bill 4146 on page 3 by |
| 3 | | replacing lines 13 through 16 with the following:
|
| 4 | | "This paragraph (3) does not prohibit a health care |
| 5 | | plan from removing a brand name drug or changing its |
| 6 | | preferred or tiered cost-sharing if the plan adds a |
| 7 | | therapeutically equivalent generic drug (as determined by |
| 8 | | the United States Food and Drug Administration) if such |
| 9 | | generic drug was not available on the market at the |
| 10 | | beginning of the enrollee's plan year if the health care |
| 11 | | plan does all of the following at least 30 days before |
| 12 | | making the formulary change: |
| 13 | | (i) provide general notification of the change in |
| 14 | | its formulary to current and prospective enrollees; |
| 15 | | and |
| 16 | | (ii) provide direct notification to enrollees |
| 17 | | currently prescribed the drug, including information |
| 18 | | on the specific drugs involved and steps they may take |